Epidemiology of myasthenia gravis in Ontario, Canada

Neuromuscular Disorders - Tập 26 - Trang 41-46 - 2016
Ari Breiner1, Jessica Widdifield2,3, Hans D. Katzberg1, Carolina Barnett1, Vera Bril1, Karen Tu2,4,5
1Department of Medicine, Division of Neurology, University of Toronto, Toronto, Ontario, Canada
2Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada
3McGill University, Montreal, Quebec, Canada
4Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
5University Health Network, Toronto Western Hospital Family Health Team, Toronto, Ontario, Canada

Tài liệu tham khảo

Silvestri, 2012, Myasthenia gravis, Semin Neurol, 32, 215, 10.1055/s-0032-1329200 Guptill, 2012, Estimated cost of treating myasthenia gravis in an insured U.S. population, Muscle Nerve, 45, 363, 10.1002/mus.22327 MacDonald, 2000, The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK, Brain, 123, 665, 10.1093/brain/123.4.665 Garland, 1956, Myasthenia gravis; a personal study of 60 cases, Br Med J, 1, 1259, 10.1136/bmj.1.4978.1259 Kurtzke, 1978, Epidemiology of myasthenia gravis, Adv Neurol, 19, 545 Eaton, 2007, Epidemiology of autoimmune diseases in Denmark, J Autoimmun, 29, 1, 10.1016/j.jaut.2007.05.002 Lai, 2010, Nationwide population-based epidemiological study of myasthenia gravis in Taiwan, Neuroepidemiology, 35, 66, 10.1159/000311012 Gattellari, 2012, A national epidemiological study of Myasthenia Gravis in Australia, Eur J Neurol, 19, 1413, 10.1111/j.1468-1331.2012.03698.x Andersen, 2014, Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries, Acta Neurol Scand Suppl, 2014, 26, 10.1111/ane.12233 Andersen, 2010, Myasthenia gravis requiring pyridostigmine treatment in a national population cohort, Eur J Neurol, 17, 1445, 10.1111/j.1468-1331.2010.03089.x Pakzad, 2011, Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada, Neurology, 76, 1526, 10.1212/WNL.0b013e318217e735 Breiner, 2015, Canadian administrative health data can identify patients with myasthenia gravis, Neuroepidemiology, 44, 108, 10.1159/000375463 Chan, 2005 2005 Carr, 2010, A systematic review of population based epidemiological studies in Myasthenia Gravis, BMC Neurol, 10, 46, 10.1186/1471-2377-10-46 Lindstrom, 1976, Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value, Neurology, 26, 1054, 10.1212/WNL.26.11.1054 Phillips, 1996, Epidemiologic evidence for a changing natural history of myasthenia gravis, Neurology, 47, 1233, 10.1212/WNL.47.5.1233 2015